Trial Profile
Pivotal Bioequivalence Study of Videx Chewable/Dispersible Buffered Tablets and an Encapsulated Enteric Coated Bead Formulation of Didanosine in HIV-Infected Subjects
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 09 Jun 2009
Price :
$35
*
At a glance
- Drugs Didanosine (Primary)
- Indications HIV infections
- Focus Pharmacokinetics; Registrational
- Sponsors Bristol-Myers Squibb
- 09 Jun 2009 New trial record.